# #54–Kevin Sayer, CEO of Dexcom: Continuous glucose monitors–impact of food, sleep, & stress

**Channel:** Peter Attia MD
**Upload Date:** 2020-01-10
**URL:** https://www.youtube.com/watch?v=W8JWAQq8i-Q
**Duration:** 104 minutes

## Description

Full title: #54 – Kevin Sayer, CEO of Dexcom: Continuous glucose monitors – impact of food, sleep, and stress on glucose, the unmatched power of CGM to drive behavioral change, and the exciting future of CGM

Original release date: 5/20/19

In this episode, Kevin Sayer, CEO of Dexcom, discusses the remarkable benefits of a continuous glucose monitor for the diabetes population. Peter shares his own invaluable insights he’s learned from wearing a CGM including the impact of sleep and stress on glucose as well as the unmatched power of a CGM to drive behavioral change. Kevin also reveals some of the exciting partnerships and future advancements of their products benefiting not only those with type 1 and 2 diabetes, but also for the growing community of people interested in optimizing health and wellness.

We discuss:
-How they met, and Kevin’s path to becoming CEO of Dexcom [7:00];
-How CGM technology works, and what makes Dexcom’s G6 the best model yet [15:15];
-Challenges of working in the US healthcare system and getting CGM insured [21:45];
-Developing an even smaller, more user-friendly, and less costly product while maintaining performance and accuracy [33:15];
-Next thing on the horizon for type 1 diabetes patients [43:30];
-The incredible accuracy of the G6, recommended over-the-counter glucose meters, and the unmatched power of CGM to drive behavioral change [48:15];
-Software improvements for type 2 diabetics, and the remarkable benefits of real-time feedback for driving behavioral change [58:15];
-Dexcom vs. the competitors, the less invasive options, and the fundamental problems needing to be solved with CGM technologies [1:07:00];
-The cost of CGM, why you need a prescription, and when might there be a OTC option? [1:12:00];
-Smartwatch integration, bluetooth technology, and exciting collaborations and partnerships [1:22:00];
-Future places for CGM: Hospitals, nutrition apps, general health and wellness, and more [1:27:15];
-Dexcom’s unique company culture [1:34:15];
-Parenting advice from Kevin [1:37:30];
-Lessons learned through failures and success [1:38:45]; and
-More.

Show notes page: https://peterattiamd.com/kevinsayer/

About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. 

Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com/
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Play: http://bit.ly/TheDriveGooglePlay

## AI Summary

Here's a comprehensive analysis of the podcast episode with Kevin Sayer, CEO of Dexcom:

1. **Executive Summary**:
This episode focuses on continuous glucose monitoring (CGM) technology, specifically Dexcom's devices and their impact on diabetes management and health optimization. Kevin Sayer discusses the evolution of CGM technology, its current applications, and future potential in both medical and wellness contexts. The conversation covers technical aspects of glucose monitoring, regulatory challenges, and the broader implications for healthcare.

2. **Key Medical/Scientific Points**:
- CGM works through a thin wire inserted subcutaneously that generates electrochemical signals [00:15:43]
- Sensor sits approximately half-inch under the skin at an angle [00:13:42]
- G6 device shows significant accuracy improvements over previous models [00:19:55]
- Approximately 1.5 million people in US have Type 1 diabetes [00:21:56]
- Only 20-30% of Type 1 diabetics currently use CGM [00:22:45]

3. **Health Optimization Tips**:
Universal Recommendations:
- Real-time glucose monitoring can drive behavioral change [00:37:41]
- Exercise can temporarily spike glucose but lower average levels throughout the day [01:05:48]

Context-specific:
- Sleep quality significantly impacts glucose levels [01:07:38]
- Stress can significantly affect glucose readings [00:54:41]

4. **Nutrition & Diet**:
- Grapes and raisins can cause dramatic glucose spikes [01:03:43]
- Trail mix with M&Ms can spike glucose to 130-160 [01:04:04]
- Post-exercise glucose response to food differs significantly from normal state [01:05:48]

5. **Biomarkers & Testing**:
- Standard deviation of glucose may be more informative than average levels [00:49:50]
- Hemoglobin A1C has limitations as a metric [00:54:41]
- Continuous monitoring provides more accurate picture than spot checks [00:37:41]

6. **Notable Quotes**:
"You can pay now or pay later" - regarding healthcare interventions [01:29:40]
"Performance and accuracy will always be our core principle" [00:35:14]

7. **Follow-up Questions**:
- What is the potential for non-glucose analytes to be measured via CGM?
- How might CGM technology evolve for non-diabetic populations?
- What role might CGM play in preventive medicine?
- How can CGM data be better integrated with other health metrics?

This analysis captures the main points while maintaining the timestamp references as requested. Would you like me to expand on any particular section?
